杜皮鲁玛
医学
安慰剂
特应性皮炎
湿疹面积及严重程度指数
内科学
临床终点
随机对照试验
安慰剂对照研究
斯科拉德
皮肤科生活质量指数
胃肠病学
皮肤病科
疾病
双盲
病理
替代医学
作者
Eric L. Simpson,Thomas Bieber,Emma Guttman‐Yassky,Lisa A. Beck,Andrew Blauvelt,Michael J. Cork,Jonathan I. Silverberg,Mette Deleuran,Yoko Kataoka,J.‐P. Lacour,Külli Kingo,Margitta Worm,Yves Poulin,Andreas Wollenberg,Yuhwen Soo,Neil M.H. Graham,Gianluca Pirozzi,Bolanle Akinlade,Heribert Staudinger,Vera Mastey
标识
DOI:10.1056/nejmoa1610020
摘要
Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of atopic or allergic diseases such as atopic dermatitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI